Utopic Tech

Pune, India Founded: 2019 • Age: 7 yrs
Medical device for kidney diagnosis and management is developed.

About Utopic Tech

Utopic Tech is a Healthcare company based in Pune (India) founded in 2019 by Mehul Baldwa. Medical device for kidney diagnosis and management is developed. Utopic Tech has raised $39.94 thousand across 2 funding rounds from investors including Pfizer, Startups at Venture Center and Social Alpha. Utopic Tech was last valued at $345.57 thousand in October 2021. Its chief executive, as recorded, is Mehul Baldwa. Its Indian entity Utopic Tech Private Limited reported revenue of β‚Ή20 Lakh. Utopic Tech offers products and services including Creasens. Its focus areas include Life Sciences, Nephrology, Medical Devices and Monitoring Devices.

Company details

Utopic Tech was founded in 2019 in Pune, India, and operates in the medical devices sector. Focus is placed on kidney-related health solutions, with the primary product Creasens enabling creatinine measurement from finger-prick samples in under a minute. Development and management of diagnostic tools for renal conditions are prioritized, supporting clinical applications in healthcare settings across the region.

Operational Areas
Key Metrics
  • Annual Revenue
    ₹20 Lakh

    FY 2024 · -19% YoY

  • Net Loss
    -₹9.7 Lakh

    FY 2024 · -49% margin

  • EBITDA
    -₹12.4 Lakh

    FY 2024 · -62% margin

  • Total Equity Funding
    $39.94K (USD)

    in 2 rounds

  • Latest Funding Round
    $29.62K (USD), Grant

    Nov 2024

  • Investors
    Pfizer

    & 2 more

Products & Services of Utopic Tech

Utopic Tech offers a comprehensive portfolio of products and services, including Creasens.

Creasens
Diagnostic Device

Measures creatinine from finger prick for quick kidney diagnosis.

Funding Insights of Utopic Tech

Utopic Tech has successfully raised a total of $39.94K across 2 strategic funding rounds. The most recent funding activity was a Grant round of $29.62 thousand completed in November 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $39,942
  • Total Rounds 2
  • Last Round Grant β€” $29,620
  • First Round $39,942

    (Oct 2021)

  • Investors Count 3

All 2 funding rounds of Utopic Tech with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Nov 2024$29,620Grant–Pfizer
Oct 2021$39,942Seed$345,570Startups at Venture Center
–
Valuation history

Last known valuation $345,570 (Oct 2021). 3 investors in total: 3 institutional.

Investors in Utopic Tech

Utopic Tech has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Pfizer, Startups at Venture Center and Social Alpha.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Sustainable startups are supported via innovation curation and venture funding.
socialalpha.orgBengaluru, India
Startup incubator focused on science business
startups.venturecenter.co.in
Pharmaceutical products for treating multiple diseases are provided.
1849pfizer.comNew York, United States
Premium access

Investor details for Utopic Tech

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Utopic Tech Private Limited (Utopic Tech)

Utopic Tech Private Limited is the primary company behind Utopic Tech. The board of Utopic Tech Private Limited currently have 2 directors; the longest-serving is Mehul Baldwa, appointed in 2019. 2 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Mehul Baldwa
DIN 08586408
Director14 Oct 20197 yrs 1 moUtopic Tech Private Limited
Sanjay Kumar Baldwa
DIN 08586409
Director14 Oct 20197 yrs 1 moUtopic Tech Private Limited

People of Utopic Tech

1 people are tracked at Utopic Tech (1 in leadership).

NameRoleGroup
Founder & CEOLeadership
Premium access

Complete people profiles for Utopic Tech

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Utopic Tech

Figures of Utopic Tech Private Limited, the primary company behind Utopic Tech, for FY 2024. Revenue was ₹20 Lakh (-19% year on year). Net loss was -₹9.7 Lakh (-49% margin). EBITDA was -₹12.4 Lakh (-62% margin). Revenue has grown at a compounded annual rate of +35% over three years.

  • ₹20 LakhRevenue · FY 2024 · -19% YoY
  • -₹9.7 LakhNet loss · -49% margin
  • -₹12.4 LakhEBITDA · -62% margin
  • ₹1.1 LakhPaid-up capital
  • +35%Revenue CAGR, 3 years

Balance sheet, profit and loss, cash flow and ratios of Utopic Tech Private Limited are on its company page.

Premium access

Detailed financial statements for Utopic Tech

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of Utopic Tech

3 dated milestones of Utopic Tech across 5 years, from founding to its latest funding, stage changes and deals.

  1. Founded Utopic Tech is founded.
  2. Funding First funding round of $40K.
  3. Funding Latest funding round, Grant, of $30K.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Utopic Tech

Utopic Tech was founded in 2019 and raised its 1st funding round 2 years after it was founded.

Utopic Tech is headquartered in Pune, India. It is registered at Pune, Maharashtra, India.

Mehul Baldwa is the CEO of Utopic Tech, as recorded in our data. They have also founded this company.

Utopic Tech is a funded company, having raised a total of $39.94K across 2 funding rounds to date. The company's 1st funding round was a Seed of $39.94K, raised on Oct 2021.

The primary company behind Utopic Tech, Utopic Tech Private Limited, reported revenue of β‚Ή20 Lakh for FY 2024, down 19% year on year.

Utopic Tech was founded in 2019 in Pune, India, and operates in the medical devices sector. Focus is placed on kidney-related health solutions, with the primary product Creasens enabling creatinine measurement from finger-prick samples in under a minute. Development and management of diagnostic tools for renal conditions are prioritized, supporting clinical applications in healthcare settings across the region.

Utopic Tech offers Creasens.

Utopic Tech has 3 investors. Key investors include Pfizer, Startups at Venture Center, and Social Alpha.

The valuation of Utopic Tech is $345.57K as of Oct 2021.

Utopic Tech operates through Utopic Tech Private Limited.

The legal entities of Utopic Tech currently have 2 directors, including Mehul Baldwa, Sanjay Kumar Baldwa.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available